Analysts think MURA stock price could increase by 358%
Feb 27, 2025, 12:25 PM
-64.91%
What does MURA do
Mural Oncology Plc is a clinical-stage company developing cytokine-based immunotherapies for cancer using its protein engineering platform. Its portfolio includes Nemvaleukin alfa and a tumor-targeted split IL-12 program.
6 analysts think MURA stock price will increase by 357.52%. The current median analyst target is $17.34 compared to a current stock price of $3.79. The lowest analysts target is $13.13 and the highest analyst target is $18.90.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
